Ammonul

Product manufactured by Bausch Health Us Llc

Application Nr Approved Date Route Status External Links
NDA020645 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ammonul Is Indicated As Adjunctive Therapy In Pediatric And Adult Patients For The Treatment Of Acute Hyperammonemia And Associated Encephalopathy In Patients With Deficiencies In Enzymes Of The Urea Cycle. During Acute Hyperammonemic Episodes, Arginine Supplementation, Caloric Supplementation, Dietary Protein Restriction, Hemodialysis, And Other Ammonia Lowering Therapies Should Be Considered [See Warnings And Precautions (5) ]. Ammonul Is A Nitrogen Binding Agent Indicated As Adjunctive Therapy For The Treatment Of Acute Hyperammonemia And Associated Encephalopathy In Patients With Deficiencies In Enzymes Of The Urea Cycle. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments